Ventis Medical Selects ADM Tronics to Produce New Ventilator Technology
20 Avril 2021 - 6:20PM
InvestorsHub NewsWire
Northvale, NJ -- April 20, 2021 -- InvestorsHub NewsWire
-- ADM Tronics Unlimited, Inc. (OTCQB
- ADMT) today announced that Ventis
Medical, Inc. (“VMI”), has entered into an agreement for ADMT to
provide regulatory support and manufacturing for VMI’s
next-generation, portable ventilator technology, The Ventis VM-2000
Ventilator.
VMI was founded under the clinical guidance of Glenn W. Laub,
MD, a cardiac surgeon and medical technology developer who
recognized the need for a low-cost, simple-to-use ventilator based
on his experiences witnessing certain patients critically
deteriorate while waiting for a ventilator to be applied, as well
as ventilation being delayed in emergency scenarios due to the
complexity of deploying standard ventilators.
After completing extensive development efforts and
qualifications of the Ventis VM-2000 Ventilator, VMI sought an
FDA-Registered and ISO-13485 certified medical device manufacturer
to bring the device into production. After reviewing
potential companies, VMI selected ADMT.
Karen Laub, VMI President, stated, “We are pleased to be working
with ADM Tronics to bring our Ventis VM-2000 Ventilator into volume
production. There is a significant need for a low-cost,
easy-to-use ventilator for emergency use with improved
functionality. We believe the VM-2000 fills that need,
and I am confident ADMT can help us to produce it for the
marketplace.”
ADMT will meet regulatory requirements for quantity manufacturing
of the Ventis Ventilator in ADMT’s FDA-Registered Medical Device
Manufacturing Facility in Northvale, NJ. ADMT will support
VMI in regulatory manufacturing requirements for US FDA and
international distribution.
“We are honored and pleased that VMI has chosen our company for
this important technology that can help so many people around the
world,” stated Andre’ DiMino, President and CEO of ADMT. “Our
regulatory and manufacturing teams look forward to working with Dr.
Laub and the development team at VMI to bring the Ventis Ventilator
into production for the medical marketplace.”
Based in Princeton, NJ, VMI’s unique mix of clinical,
engineering and product expertise provides the platform for this
breakthrough in ventilator technology. The Ventis Ventilator
is the only ventilator technology positioned to remove the
limitations not only on cost, but also on extensive training in
order to deliver lifesaving care where Bag Valve Devices (BVDs) are
used today. When ventilators are not available, doctors must
resort to BVDs which require an operator to manually squeeze
500mL of air every 5 seconds, or potentially forego lifesaving
care. ADMT is excited to partner with Ventis Medical to
pursue the mission of expanding access to high quality ventilatory
care globally.
About ADMT
ADMT is a diversified, technology-based developer and manufacturer
of innovative technologies and products. Its core competency
is its ability to conceptualize a technology, bring it through
development, into manufacturing and commercialization, all
in-house. ADMT has three areas of activity: Proprietary
Medical Devices; Medical Device Design, Engineering, Regulatory and
Manufacturing Services; and Eco-Friendly, Water-Based
Formulations. The Company’s headquarters, laboratories,
FDA-Registered medical device, and manufacturing operations are in
Northvale, NJ. ADMT’s multi-disciplinary team of engineers,
researchers, and technologists utilize advanced technology
infrastructure, such as rapid 3-D prototyping, precision
instrumentation and specialized software and peripherals, for
research, development, and commercialization of diversified
technologies. Additional information is available on the Company’s
website - admtronics.com.
ADMT welcomes inquiries for its medical device services via the
ADMT website – www.admtronics.com.
To receive email updates directly from ADMT, fill in the form at
the bottom of this page: https://admtronics.com/investor-relations/
Except for historical information contained herein, the matters
set forth in this news release are “forward-looking” statements (as
defined in the Private Securities Litigation Reform Act of 1995),
including statements regarding future revenue growth and
performance. Although ADMT believes the expectations
reflected in such forward-looking statements are based upon
reasonable assumptions, there can be no assurance that its
expectations will be realized. Forward-looking statements involve
risks and uncertainties that could cause actual results to differ
materially from expectations. Factors that could contribute
to such differences include those described from time to time in
ADMT’s SEC filings, news releases, and other communications. The
Company assumes no obligation to update the information contained
in this news release.
Andre DiMino
201-767-6040
andre@admtronics.com
Adm Tronics Unlimited (QB) (USOTC:ADMT)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Adm Tronics Unlimited (QB) (USOTC:ADMT)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024